- Release Date: 13/10/20 13:31
- Summary: Phase 3 Trial in COVID-19 ARDS Surpasses 50% Enrollment
- Price Sensitive: No
- Download Document 115.52KB
-
- There are more pages in this discussion • 386 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.30 |
Change
-0.010(0.43%) |
Mkt cap ! $2.943B | |||
| Open | High | Low | Value | Volume |
| $2.32 | $2.39 | $2.27 | $8.342M | 3.586M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 28 | 69818 | $2.29 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.30 | 20609 | 19 |
View Market Depth
| Last trade - 12.53pm 22/07/2025 (20 minute delay) ? |
| MSB (ASX) Chart |